SARS-CoV-2 Vaccines in Patients With Multiple Myeloma
Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892292/
COVID-19 pandemic has led to an unprecedented need to develop an effective and safe vaccine in a timely manner. SARS-CoV-2 binds to human cells via the spike (S) protein, which...
-
Mark Fesler4yrUnfortunately there is limited information on vaccine efficacy or aes in myeloma and other cancers but given the rates of severe illness, adherence to the current guidelines certainly makes sense Show More
tRNA-derived fragments and their roles in multiple myeloma | OTT
Multiple myeloma (MM) is the second most common hematological malignancy and is characterized by the accumulation of malignant plasma cells in the bone marrow. With the advent of new drugs,...
-
Mark Fesler4yrInteresting area of research identifying rna sequences that may play a role in myeloma pathogenesis
Efficacy and Safety of CAR-T Therapy for Relapse or Refractory Multiple Myeloma: A systematic review and meta-analysis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33746596/
1 Department of Hematology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China. 2 Institute of Reproductive and Stem Cell Engineering, School of Basic Medical Science, Central South...
-
Mark Fesler4yrIt will be interesting to see, now that there is an fda approved myeloma car, what the uptake of this therapy will be in the real world as providers weigh Show More
-
Multiple Myeloma Connect4yrKey points • Dutch researchers assessed the optimal sequence of treatment for patients with non-transplant eligible (NTE) multiple myeloma (MM) from patient, physician, and society vantage points. They assessed 30 treatment sequences, Show More
Immune-related expression profiles of bisphosphonates-related osteonecrosis of the jaw in multiple myeloma - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33849701/
Objective: To investigate the immune cellular and genomic profiles of bisphosphonates-related osteonecrosis (BRONJ) of the jaw and excavate potential small molecule drugs. Methods and materials: The genomic profile of a...
